Versant Ventures III, LLC's Net Worth
$73.7 Million
Who is Versant Ventures III, LLC?
Versant Ventures III, LLC has an estimated net worth of $73.7 Million. This is based on reported shares across multiple companies, which include PHASERX, INC., VERACYTE, INC., OPGEN INC, Skye Bioscience, Inc., and Flexion Therapeutics Inc.
SEC CIK
Versant Ventures III, LLC's CIK is 0001456587
Past Insider Trading and Trends
2015 was Versant Ventures III, LLC's most active year for acquiring shares with 10 total transactions. Versant Ventures III, LLC's most active month to acquire stocks was the month of April. 2015 was Versant Ventures III, LLC's most active year for disposing of shares, totalling 6 transactions. Versant Ventures III, LLC's most active month to dispose stocks was the month of April. 2016 saw Versant Ventures III, LLC paying a total of $12,999,990.00 for 1,314,285 shares, this is the most they've acquired in one year. In 2016 Versant Ventures III, LLC cashed out on 258,044 shares for a total of $2,580.44, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
PHASERX, INC. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +21.36% | 341.96K |
$2.51 | $2,997,419.56 | 1.94M |
May 23
| |||
Form 3/A
|
—
|
0
|
—
|
—
|
0
| ||||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Flexion Therapeutics Inc No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +25.35% | 714.28K |
$14.00 | $9,999,990.00 | 3.53M |
Jun 8
| |||
Form 4
|
∞
| 2.25K |
$17.61 | $39,622.50 | 2.25K |
Sep 10
| |||
| No matching records found | |||||||||
VERACYTE, INC. (VCYT) Snapshot price: $24.42
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 3.62M |
—
|
—
| 3.62M |
Nov 4
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
OPGEN INC (OPGN) Snapshot price: $0.35
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +3,418.54% | 2.48M |
$6.00 |
—
| 2.55M |
May 8
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Skye Bioscience, Inc. (SKYE) Snapshot price: $4.98
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||